Efficacy of live, attenuated, human rotavirus vaccine 89–12 in infants: a randomised placebo-controlled trial
- 1 July 1999
- journal article
- clinical trial
- Published by Elsevier BV in The Lancet
- Vol. 354 (9175), 287-290
- https://doi.org/10.1016/s0140-6736(98)12106-2
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- The protective effectiveness of natural rotavirus infection in an American Indian population.The Journal of Infectious Diseases, 1998
- Cost-effectiveness Analysis of a Rotavirus Immunization Program for the United StatesJAMA, 1998
- Safety and immunogenicity of live, attenuated human rotavirus vaccine 89-12Vaccine, 1998
- Rotavirus vaccines at the thresholdNature Medicine, 1997
- Randomised placebo-controlled trial of rhesus-human reassortant rotavirus vaccine for prevention of severe rotavirus gastroenteritisThe Lancet, 1997
- Rotavirus Infection in Infants as Protection against Subsequent InfectionsNew England Journal of Medicine, 1996
- Mechanisms Of Protection Against Rotavirus In Humans And MiceThe Journal of Infectious Diseases, 1996
- Evaluation of Rhesus Rotavirus Monovalent and Tetravalent Reassortant Vaccines in US ChildrenJAMA, 1995
- Protection against Rotavirus Disease after Natural Rotavirus InfectionThe Journal of Infectious Diseases, 1994
- Development of an improved method for measuring neutralizing antibody to rotavirusJournal of Virological Methods, 1991